Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Corcept Therapeutics (NQ: CORT )

21.00 +0.89 (+4.43%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 27, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 579,162
Open 20.11
Bid (Size) 16.70 (70)
Ask (Size) 21.15 (1)
Prev. Close 20.11
Today's Range 19.87 - 21.00
52wk Range 15.82 - 25.68
Shares Outstanding 115,926,629
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Corcept Update
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
NASDAQ:CORT Investor Alert: Investigation over Potential Wrongdoing at Corcept Therapeutics Incorporated
San Diego, CA -- (SBWIRE) -- 05/09/2022 -- Certain directors of Corcept Therapeutics Incorporated are under investigation over potential breaches of fiduciary duties. 
Via SBWire

Performance

YTD
+3.24%
+3.24%
1 Month
-1.18%
-1.18%
3 Month
-5.79%
-5.79%
6 Month
-0.57%
-0.57%
1 Year
-2.78%
-2.78%

More News

Read More
Preview: Corcept Therapeutics's Earnings
Via Benzinga
Corcept Shareholder Notice
Via NewMediaWire
Corcept Therapeutics Incorporated (NASDAQ:CORT) Shareholder Alert: Update on Lawsuit Against Corcept Therapeutics
Via SBWire
Corcept Therapeutics's Return On Capital Employed Overview
Via Benzinga
Corcept Shareholder Alert
Via NewMediaWire
Corcept Investor Alert
Via NewMediaWire
Recap: Corcept Therapeutics Q4 Earnings
Via Benzinga
The Daily Biotech Pulse: Larimar Plunges On Extension Of Clinical Hold, ImmunityBio Gains On Positive Data, Adcom Test Awaits Avenue Therapeutics
Via Benzinga
Corcept Update
Via NewMediaWire
Corcept Shareholder Notice
Via NewMediaWire
Corcept Shareholder Alert
Via NewMediaWire
Earnings Scheduled For February 15, 2022
Via Benzinga
Corcept Investor Alert
Via NewMediaWire
Corcept Update
Via NewMediaWire
Corcept Shareholder Notice
Via NewMediaWire
Corcept Shareholder Notice
Via NewMediaWire
Corcept Shareholder Alert
Via NewMediaWire
Corcept Investor Alert
Via NewMediaWire
Benzinga's Top Ratings Upgrades, Downgrades For February 2, 2022
Via Benzinga
Shareholder Alert: Robbins LLP Is Investigating the Officers and Directors of Corcept Therapeutics Incorporated (CORT)
From Robbins LLP
Via Business Wire
Corcept Investor Alert
Via NewMediaWire
Corcept Shareholder Notice
Via NewMediaWire
Corcept Shareholder Alert
Via NewMediaWire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.